From what's now to what's next in life sciences
Where there's big data, there's both risk and reward. By improving clinical trials and drug development, and assessing the potential of genome data, the life sciences industry is embracing this exciting data opportunity. What lies ahead for this data-rich industry? Read our infographic below to find out.
For more information, download our PoV
Comments
Hi,What is the core substance of the world life science research in the post genomic era?
Posted by: crispr/cas9 genome editing system | December 3, 2015 5:58 AM